The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 04, 2020
Filed:
Sep. 30, 2016
Applicant:
Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd., Shijiazhuang, Hebei, CN;
Inventors:
Ying Shi, Hebei, CN;
Yi Mi, Hebei, CN;
Hanyu Yang, Hebei, CN;
Xuliang Wang, Hebei, CN;
Denghuang Gong, Hebei, CN;
Min Bai, Hebei, CN;
Xiaozhuo Chen, Hebei, CN;
Yujie Chen, Hebei, CN;
Xuejiao Zhang, Hebei, CN;
Yuxiu Ma, Hebei, CN;
Qingzhi Gao, Hebei, CN;
Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07C 235/84 (2006.01); C07D 403/12 (2006.01); C07D 237/24 (2006.01); C07C 231/12 (2006.01); C07C 237/38 (2006.01); C07C 237/42 (2006.01); C07C 273/18 (2006.01); C07C 275/38 (2006.01); C07D 211/16 (2006.01); C07D 211/46 (2006.01); C07D 213/81 (2006.01); C07D 213/82 (2006.01); C07D 277/82 (2006.01); C07D 295/192 (2006.01); C07D 333/38 (2006.01); C07D 401/12 (2006.01); C07D 409/06 (2006.01); C07D 401/06 (2006.01);
U.S. Cl.
CPC ...
C07C 235/84 (2013.01); C07C 231/12 (2013.01); C07C 237/38 (2013.01); C07C 237/42 (2013.01); C07C 273/1854 (2013.01); C07C 275/38 (2013.01); C07D 211/16 (2013.01); C07D 211/46 (2013.01); C07D 213/81 (2013.01); C07D 213/82 (2013.01); C07D 237/24 (2013.01); C07D 277/82 (2013.01); C07D 295/192 (2013.01); C07D 333/38 (2013.01); C07D 401/06 (2013.01); C07D 401/12 (2013.01); C07D 403/12 (2013.01); C07D 409/06 (2013.01); C07C 2601/02 (2017.05); C07C 2601/08 (2017.05); C07C 2601/14 (2017.05);
Abstract
The present invention relates to a benzamide derivative of general formula I, a drug composition containing same and a use thereof as a drug, wherein the definitions of R, Z and Q are as described in the description.